Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
G. Mason Morfit currently holds 8,130,850 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, G. Mason Morfit has been a net seller of VRX stock. They have purchased $0 and sold $577.7M worth of shares.
G. Mason Morfit's most recent insider trade was on Aug 8, 2017, when they sold 278,000 shares at $72.50 per share.
G. Mason Morfit serves as Executive at Valeant Pharmaceuticals International, Inc. (VRX). They have executed 41 insider transactions totaling $577.7M over their tenure at the company.
G. Mason Morfit holds the position of Executive at Valeant Pharmaceuticals International, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
G. Mason Morfit has shown a selling trading pattern, with $0 in total purchases and $577.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by G. Mason Morfit was on Aug 4, 2017, when they sold $229.3M worth of MSFT shares. This transaction involved 3,157,400 shares at $72.61 per share.
G. Mason Morfit currently owns 8,130,850 shares of Valeant Pharmaceuticals International, Inc. (VRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of G. Mason Morfit's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. G. Mason Morfit has 41 Form 4 filings on record as an insider at Valeant Pharmaceuticals International, Inc..
Set alerts for G. Mason Morfit and 40,000+ other insiders.